© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Success as a CEO  in Drug Development
Posted 26th June 2017

Success as a CEO in Drug Development

Under the Business Elite Awards 2017, the exclusive CEO of the Year - Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Success as a CEO in Drug Development
Image

Under the Business Elite Awards 2017, the exclusive CEO of the Year – Italy award when in the direction of Francesco Sinigaglia, CEO and cofounder of Anabasis. We spoke to the man himself to find out more about his key role in the company, before he sold it to Dompé in 2011.

Francesco Sinigaglia is the CEO and co-founder of Anabasis, an Italian biopharmaceutical company developing Nerve Growth Factor (NGF) for severe eye diseases. In 2011, he sold Anabasis to Dompé for approximately 10 million upfront and 160 million in regulatory and commercial milestones. Francesco’s industry expertise lies in the life science, biotechnology and pharmaceutical sectors.

He starts the interview by detailing his role following the acquisition and his undoubted experience as a seasoned professional in the industry, plus his reflections on his greatest professional achievement to date.

“After the acquisition, I remained on board as COO to complete the development of the NGF. It was a great success, indeed NGF is now being approved in the EU by European Medicines Agency (EMA).

“Going back a bit, I spent more than 35 years in the biotech and pharmaceutical industry. This included 20 years at Roche, with the first 10 of these at the company’s headquarters in Basel and then as a research director in Italy. In 2002, I founded my first biotech company, Bioxell, that I took public on the Swiss Stock Exchange in 2006 and sold it to Cosmo Pharmaceutical three years later. In 2009, I founded the company Anabasis.

“My biggest achievement is the success of Anabasis, both in terms of scientific and clinical development and for the ability to create value. We financed the development programmes by ourselves and through the collaboration agreement with Dompé, thus avoiding the financial support of venture capital and consequently value dilution.”

Francesco then offers his thoughts on what makes him stand out from other CEO’s and the advice he would you give to anyone wishing to pursue the same career route.

“Drug development is a difficult and risky business. Indeed, only a very few drugs are approved each year and these are mostly from large multinational organisations. To have been able, with rather limited resources, to complete the preclinical, clinical and regulatory development and obtain approval by the regulatory authorities is indeed for me a very major achievement.

“For anybody wishing to take the same career route as me, I would underline that, if you believe that you have a good business idea, just go for it don’t be afraid to fail. It is very true to say that failure is a very important component of the learning process.”

Finally, Francesco draws our attention to another accolade he has won over the past 12 months, including the Best Biopharmaceutical Company – Italy and Excellence Award for Industrial Research 2017, as well as the Business Elite Awards 2017 CEO of the Year – Italy award that this feature interview celebrates.

Categories: Leadership


You Might Also Like
Read Full PostRead - Eye Icon
IAG: Ensuring Everyone Benefits
Strategy
23/02/2018IAG: Ensuring Everyone Benefits

Insurance Applications Group (IAG) is a licensed National Employee Benefits Firm specializing in the product design, communication and administrative processes of supplemental insurance products for specific vertical markets.

Read Full PostRead - Eye Icon
Next-Generation Retail Solutions
News
08/08/2023Next-Generation Retail Solutions

Vision Group has become a renowned conglomerate on the world stage thanks to an outlook and mission to deliver best in class, technology-driven solutions that reinvigorate the ever-moving retail landscape.

Read Full PostRead - Eye Icon
DAC Group Acquisition Introduces New Technology to UK Based Make It Rain
Finance
25/04/2015DAC Group Acquisition Introduces New Technology to UK Based Make It Rain

DAC Group Acquisition Introduces New Technology to UK Based Make It Rain

Read Full PostRead - Eye Icon
Intertwining Technology to Solve Business Solutions
Innovation
30/08/2019Intertwining Technology to Solve Business Solutions

Globus Eight Inc provides IT security and support, healthcare domain support and IoT framework services. Following their recent success in AI’s Global Excellence Awards 2019, we profiled the firm and caught up with CEO, Alok Sinha who provided us with a deta

Read Full PostRead - Eye Icon
Poll Reveals Most UK Workers Are Putting IT Networks At Risk
Leadership
12/12/2019Poll Reveals Most UK Workers Are Putting IT Networks At Risk

Nearly half of working Brits are visiting sites or opening email attachments that could cause a virus, malware or ransomware attack, according to a new UK-wide study commissioned for strategic IT consultancy, Aura Technology*. The anonymous poll of 2,000 offic

Read Full PostRead - Eye Icon
Franklin advises Altice for the sale of stakes
M&A
25/06/2018Franklin advises Altice for the sale of stakes

Franklin advises Altice for the sale of stakes in its French and Portuguese telecom tower business

Read Full PostRead - Eye Icon
Pohjola Asset Management
Finance
21/05/2015Pohjola Asset Management

Helsinki-based OP Wealth Management’s R2 Crystal Fund invests in 10-15 different hedge funds across a wide range of strategies. Jussi Kärävä, Head of Fund Selection, told us more about its ongoing success.

Read Full PostRead - Eye Icon
13 Rules to Trade ETH with Credit Card in 2023
Finance
22/02/202313 Rules to Trade ETH with Credit Card in 2023

Ethereum — the world’s second-largest cryptocurrency — is often traded with a credit card. Today, there are many cryptocurrency exchanges that support credit card payments and there are even a few which specialize in Ethereum.

Read Full PostRead - Eye Icon
New product Increases Engagement In Games
Finance
06/08/2015New product Increases Engagement In Games

Mobile Engagement Company First to Unite the Power of Predictive Analytics and Mobile Messaging to Target Key Player Groups, Generating Impressive Results Including 11% Decrease in Churn, 18% Increase in Number of Sessions and 50% Increase in Revenue.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow